Patents by Inventor Matthew J. Kipper

Matthew J. Kipper has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR COATING BONE ALLOGRAFTS WITH PERIOSTEUM-MIMETIC TISSUE ENGINEERING SCAFFOLDS
    Publication number: 20150086602
    Abstract: Methods of coating bone surfaces and coated bones comprising a coating comprising (a) a porous polysaccharide scaffold and/or a plurality of polysaccharide nanofibers; and (b) a polyelectrolyte multilayer composition, are disclosed. The methods of coating bone surfaces and the coated bones disclosed provide a biomimetic periosteum to compensate for periosteum lost in preparing bone grafts, and the coated bone grafts, including allografts, restore lost osteogenic and osteoinductive qualities and improve clinical outcomes.
    Type: Application
    Filed: September 25, 2014
    Publication date: March 26, 2015
    Inventors: Matthew J. Kipper, Nicole P. Ehrhart, Raimundo Romero, Timothy R. Gonzales
  • Controlled-release immunogenic formulations to modulate immune response
    Patent number: 8173104
    Abstract: Single-dose controlled-release immunogenic formulations, such as vaccines, based on bioerodible polyanhydride copolymer or homopolymer microparticles for the control of immune response mechanisms are provided. The copolymer or homopolymer microparticles degrade by surface-erosion from in vivo hydrolysis of anhydride linkages at the surface of the microparticle, which results in controlled release of immunogen(s) to a patient.
    Type: Grant
    Filed: September 4, 2009
    Date of Patent: May 8, 2012
    Assignee: Iowa State University Research Foundation, Inc.
    Inventors: Matthew J. Kipper, Balaji Narasimhan, Jennifer H. Wilson, Michael J. Wannemuehler
  • Controlled-release immunogenic formulations to modulate immune response
    Patent number: 7858093
    Abstract: Single-dose controlled-release immunogenic formulations, such as vaccines, based on bioerodible polyanhydride copolymer or homopolymer microparticles for the control of immune response mechanisms are provided. The copolymer or homopolymer microparticles degrade by surface-erosion from in vivo hydrolysis of anhydride linkages at the surface of the microparticle, which results in controlled release of immunogen(s) to a patient.
    Type: Grant
    Filed: October 28, 2005
    Date of Patent: December 28, 2010
    Assignee: Iowa State University Research Foundation, Inc.
    Inventors: Matthew J. Kipper, Balaji Narasimhan, Jennifer H. Wilson, Michael J. Wannemuehler
  • CONTROLLED-RELEASE IMMUNOGENIC FORMULATIONS TO MODULATE IMMUNE RESPONSE
    Publication number: 20100021546
    Abstract: Single-dose controlled-release immunogenic formulations, such as vaccines, based on bioerodible polyanhydride copolymer or homopolymer microparticles for the control of immune response mechanisms are provided. The copolymer or homopolymer microparticles degrade by surface-erosion from in vivo hydrolysis of anhydride linkages at the surface of the microparticle, which results in controlled release of immunogen(s) to a patient.
    Type: Application
    Filed: September 4, 2009
    Publication date: January 28, 2010
    Applicant: Iowa State University Research Foundation, Inc.
    Inventors: Matthew J. Kipper, Balaji Narasimhan, Jennifer H. Wilson, Michael J. Wannemuehler